Ferric Citrate

CHEMBL3301597 Phase 4 Aprovado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
244.9 g/mol
LogP
Phase
4

This iron compound is used to control phosphate levels in the blood of patients with chronic kidney disease on dialysis while also providing a source of absorbable iron. It binds dietary phosphate in the gut, preventing its absorption and reducing dangerous phosphate buildup.

Peso Molecular

244,9400 g/mol

TPSA

141,00 Ų

Áreas Terapêuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Fe+3]

InChI

InChI=1S/C6H8O7.Fe/c7-3(8)1-6(13,5(11)12)2-4(9)10;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;+3/p-3

Molecular Formula

C6H5FeO7

HBD / HBA

1 / 7

Ligações Rotacionáveis

2

Átomos Pesados

14

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

This iron compound is used to control phosphate levels in the blood of patients with chronic kidney disease on dialysis while also providing a source of absorbable iron. It binds dietary phosphate in the gut, preventing its absorption and reducing dangerous phosphate buildup.

Yes, Ferric Citrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3301597. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 61300. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.